Cite
D'Onofrio N, Sardu C, Trotta MC, et al. Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment. Mol Metab. 2021;54:101337doi: 10.1016/j.molmet.2021.101337.
D'Onofrio, N., Sardu, C., Trotta, M. C., Scisciola, L., Turriziani, F., Ferraraccio, F., Panarese, I., Petrella, L., Fanelli, M., Modugno, P., Massetti, M., Marfella, L. V., Sasso, F. C., Rizzo, M. R., Barbieri, M., Furbatto, F., Minicucci, F., Mauro, C., Federici, M., Balestrieri, M. L., Paolisso, G., & Marfella, R. (2021). Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment. Molecular metabolism, 54101337. https://doi.org/10.1016/j.molmet.2021.101337
D'Onofrio, Nunzia, et al. "Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment." Molecular metabolism vol. 54 (2021): 101337. doi: https://doi.org/10.1016/j.molmet.2021.101337
D'Onofrio N, Sardu C, Trotta MC, Scisciola L, Turriziani F, Ferraraccio F, Panarese I, Petrella L, Fanelli M, Modugno P, Massetti M, Marfella LV, Sasso FC, Rizzo MR, Barbieri M, Furbatto F, Minicucci F, Mauro C, Federici M, Balestrieri ML, Paolisso G, Marfella R. Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment. Mol Metab. 2021 Sep 07;54:101337. doi: 10.1016/j.molmet.2021.101337. Epub 2021 Sep 07. PMID: 34500107; PMCID: PMC8473552.
Copy
Download .nbib